Researchers have shown that a tiny nanoparticle formulation of saponin, along with an inflammation-promoting molecule called ...

Researchers from MIT and Scripps have unveiled a promising new HIV vaccine approach that generates a powerful immune response ...

The approach employed by the research team could be used against other diseases—including COVID-19 and influenza.

The U.S. has approved the world's only twice-a-year shot to prevent HIV, maker Gilead Sciences announced Wednesday.

The breakthrough double injection won’t be cheap in the US, although scientists argue it could (and should) be.

Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be ...

The Food and Drug Administration approved a new vaccine to prevent HIV infection, lenacapavir, a long-acting injection, which ...

The approval could slow new infections and move the world closer to eliminating HIV. But huge obstacles remain.

The Trump administration's plan to cut funding for HIV vaccine research comes at a time when the field is making substantial ...

Researchers from MIT and Scripps have unveiled a promising new HIV vaccine approach that generates a powerful immune response ...